Orgenesis Inc.·5

Feb 14, 4:47 PM ET

Nanda Ashish 5

5 · Orgenesis Inc. · Filed Feb 14, 2022

Insider Transaction Report

Form 5
Period: 2021-12-31
Nanda Ashish
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-16+15,85015,850 total
    Exercise: $2.89From: 2022-12-16Exp: 2031-12-15Common Stock (15,850 underlying)
Footnotes (1)
  • [F1]On December 16, 2021, the Board granted the Reporting Person options to purchase 15,850 shares at the exercise price of $2.89 per share. The options vest in full one year from the date of grant.

Documents

1 file
  • 5
    ownership.xmlPrimary